55 SPXIQ

INCY Incyte Corporation

Healthcare · Biotechnology

$100.02 +7.1% upside
Mean Target
$107.09
Consensus
2.3 - Buy
Analysts
22
Rank
#168 / 499
Upside Rank
#302
Analyst Price Target Distribution
$71
Low
$107
Median
$107
Mean
$135
High
Current $100
Mean $107
Median $107
86 estimates
Consensus
2.3 - Buy
52-Wk Low
$53.56
52-Wk High
$112.29
50-Day Avg
$102.29
Recent Analyst Ratings
FirmRatingTargetPriorDate
Barclays Overweight $117 $116 2026-02-18
RBC Capital Sector Perform $92 $95 2026-02-11
Stifel Buy $120 $119 2026-02-11
Wells Fargo Equal-Weight $101 $107 2026-02-11
HC Wainwright & Co. Buy $135 $135 2026-02-11
Healthcare Peers
ABT ABBV A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CRL CI COO CVS DHR DVA DXCM EW ELV GEHC